HDFC Pharma and Healthcare Fund - Growth Option
Category: Equity: Sectoral-Pharma and Healthcare |
Launch Date: 05-10-2023 |
Asset Class: Equity |
Benchmark: BSE Healthcare Index |
Expense Ratio: 2.14% As on (30-12-2024) |
Status: Open Ended Schemes |
Minimum Investment: 100.0 |
Minimum Topup: 100.0 |
Total Assets: 1,577.12 Cr As on (31-12-2024) |
Turn over: - |
16.246
0.2 (1.2065%)
46.4%
BSE Healthcare Index 15.29%
PERFORMANCE of HDFC Pharma and Healthcare Fund - Growth Option
Scheme Performance (%)
Data as on - 14-01-2025Yearly Performance (%)
Fund Managers
Dhruv Muchhal, Nikhil Mathur
Investment Objective
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
NAV & Lumpsum details( Invested amount 1,00,000)
NAV Date | NAV | Units | Market Value |
Returns (%) |
---|---|---|---|---|
04-10-2023 | 9.965 | 10035.1229 | 100000 | 0.0 % |
06-11-2023 | 10.067 | - | 101024 | 1.02 % |
04-12-2023 | 10.912 | - | 109503 | 9.5 % |
04-01-2024 | 11.664 | - | 117050 | 17.05 % |
05-02-2024 | 12.161 | - | 122037 | 22.04 % |
04-03-2024 | 12.243 | - | 122860 | 22.86 % |
04-04-2024 | 12.392 | - | 124355 | 24.36 % |
06-05-2024 | 12.683 | - | 127275 | 27.27 % |
04-06-2024 | 12.273 | - | 123161 | 23.16 % |
04-07-2024 | 13.458 | - | 135053 | 35.05 % |
05-08-2024 | 14.543 | - | 145941 | 45.94 % |
04-09-2024 | 15.863 | - | 159187 | 59.19 % |
04-10-2024 | 16.037 | - | 160933 | 60.93 % |
04-11-2024 | 16.297 | - | 163542 | 63.54 % |
04-12-2024 | 16.582 | - | 166402 | 66.4 % |
06-01-2025 | 16.906 | - | 169654 | 69.65 % |
14-01-2025 | 16.246 | - | 163031 | 63.03 % |
RETURNS CALCULATOR for HDFC Pharma and Healthcare Fund - Growth Option
Growth of 10000 In SIP (Fund vs Benchmark)
Growth of 10000 In LUMPSUM (Fund vs Benchmark)
Rolling Returns
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
Riskometer
Key Performance and Risk Statistics of HDFC Pharma and Healthcare Fund - Growth Option
Key Statistics | Volatility | Sharpe Ratio | Alpha | Beta | Yield to Maturity | Average Maturity |
---|---|---|---|---|---|---|
HDFC Pharma and Healthcare Fund - Growth Option | - | - | - | - | - | - |
Equity: Sectoral-Pharma and Healthcare | - | - | - | - | - | - |
PEER COMPARISION of HDFC Pharma and Healthcare Fund - Growth Option
PORTFOLIO ANALYSIS of HDFC Pharma and Healthcare Fund - Growth Option
Asset Allocation (%)
Allocation | Percentage (%) |
---|
Market Cap Distribution
Small Cap
37.85%
Others
1.97%
Large Cap
36.83%
Mid Cap
23.35%
Total
100%